Название документа

Amizon is an antiviral means for system use. Амизон® it is shown for treatment and prevention of flu and acute respiratory viral infections.

Structure

  • 1 tablet contains амизона® (an enisamiuma of iodide) 250 mg (0.25 g);
  • excipients: lactose, cellulose microcrystalline, povidone, sodium of a kroskarmelloz, calcium stearate;
  • cover: OPADRY II Clear 85F19250 (polyethyleneglycol, polysorbate 80, polyvinyl alcohol, talc).

Contraindication

Hypersensitivity to medicaments which contain iodide, molecular iodine or covalently connected iodine and also to other components of drug.

Route of administration

Tablet of an enisamium of iodide swallow of

, without chewing in 2 hours prior to food.

Maximum single dose - 1000 mg (1 g), the maximum daily dose - 2000 mg (2 g).

Treatment. The adult enisamium iodide 2 times a day appoint in a dose 500 mg (0.5 g) 3 times or 1000 mg (1 g).

to Children 12 years enisamium iodide are more senior than

appoint in a dose 500 mg (0.5 g) 3 times a day.

to Children aged from 6 up to 12 years are appointed on 125 mg (0.125 g) by 2-3 times a day.

treatment Duration - 7 days.

Prevention. To adults and children 16 years - on 250 mg (0.25 g) within 3-5 days, further - on 250 mg (0.25 g) of 1 times in 2-3 days within 2-3 weeks to children of 6-12 years - on 125 mg (0.125 g) every other day within 2-3 weeks to children aged from 12 up to 16 years - on 250 mg (0.25 g) every other day within 2-3 weeks are more senior.

Reception of an enisamium of iodide leads

Feature of use

to increase in level of iodide in plasma. Secondary increase in level of the circulating iodide starts the mechanism of self-control of function of a thyroid gland at which capture of inorganic iodide thyrocytes is suppressed that promotes prevention of excess formation of thyroid hormones; at the same time the level of thyroid stimulating hormone (Wolf-Chaykov's phenomenon) tranzitorno increases. This effect lasts several days; after the treatment termination the function of a thyroid gland is normalized. Tranzitorny increase in thyroid stimulating hormone within several weeks was in some cases observed.

Pregnant

it is contraindicated to p to use medicament during pregnancy as clinical trials of an enisamium of iodide with participation of pregnant women were not conducted.

Children

not to use Drug in this dosage form to children up to 6 years.

Drivers

Administration of medicament of Amizon® does not affect ability to run motor transport or work with mechanisms.

Overdose

No messages about overdose were received by the medicament Amizon® in clinical trials and at post-registration use.

Specific antidote does not exist.

Side effects

Infection and invasion: folliculitis, nasopharyngitis, rhinitis.

from respiratory organs, a thorax and mediastinum: asthma.

from blood and lymphatic system: lymphadenopathy.

from nervous system: headache, dizziness.

from an organ of sight: the century swelled.

Storage conditions

to Store

in the place protected from light at a temperature not above 25 °C.

to Store

out of children's reach.

Characteristics
Active ingredients Amizon
Amount of active ingredient 250 mg
Applicant Pharmak
Code of automatic telephone exchange Enisamiya's J05AX17 iodide
Interaction with food Later
Light sensitivity Sensitive
Market status Original
Origin Chemical
Prescription status Without prescription
Primary packing blister
Producer PUBLIC JOINT STOCK COMPANY PHARMAK
Quantity in packing 40 tablets (2 blisters on 20 pieces)
Release form tablets for internal use
Route of administration Oral
Sign Domestic
Storage temperature from 5 °C to 25 °C
Trade name Amizon

Reviews Amizon of the tab. of p/o 0.25g No. 40

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Amizon of the tab. of p/o 0.25g No. 40

  • Product Code: 183035
  • In Stock

  • Ready to ship
  • $33.85


Related Products

Last Viewed

Модули для Opencart